Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Sigilon Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
08/16/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/15/2023 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Unknown transaction of 683,760 shares @ $14.92, valued at $10.2M
Unknown transaction of 113,960 shares @ $14.92, valued at $1.7M
08/14/2023 SC 13D/A ELI LILLY & Co reports a 100% stake in Sigilon Therapeutics, Inc.
08/14/2023 4 ELI LILLY & Co (10% Owner) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Bought 1,718,493 shares @ $14.92, valued at $25.6M
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/11/2023 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of the Company (filed herewith)",
"Amended and Restated Bylaws of the Company (filed herewith)"
08/11/2023 4 Cole Douglas G. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
08/11/2023 4 Oesterle Stephen N. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
Disposed/sold 4,273 options to buy @ $7.51, valued at $32.1k
08/11/2023 4 Shaff Eric D. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
08/11/2023 4 RUFFOLO ROBERT R (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
Disposed/sold 3,754 options to buy @ $7.51, valued at $28.2k
08/11/2023 4 Cox John (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 341 shares @ $0
Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
08/11/2023 4 Kowalsky Matthew Paul (CHIEF OF STAFF AND CLO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 1,925 shares @ $0
Disposed/sold 12,690 options to buy @ $0.75, valued at $9.5k
08/11/2023 4 Patel Kavita (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
08/11/2023 4 Ashton-Rickardt Philip (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 8,845 options to buy @ $0.75, valued at $6.6k
08/11/2023 4 Yuan Qing Sarah (CTOO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 2,884 shares @ $0
Disposed/sold 8,846 options to buy @ $0.75, valued at $6.6k
08/11/2023 4 Vivaldi Coelho Rogerio (PRESIDENT AND CEO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 12,169 shares @ $0
Disposed/sold 35,382 options to buy @ $0.75, valued at $26.5k
08/11/2023 4 Pontes Josias (CFO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 3,504 shares @ $0
Disposed/sold 10,767 options to buy @ $0.75, valued at $8.1k
08/11/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/10/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/10/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/01/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
07/27/2023 4 Yuan Qing Sarah (CTOO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Exercised 2,884 options to buy @ $19.24, valued at $55.5k
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
07/18/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
07/13/2023 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy